Payment overview · 2025
General Payments
1 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|General Practice · EMMETSBURG, IA · NPI 1538226758
Verified facts
CMS Open Payments records show Thomas Jude Getta, MD received $18.80 in general payments during 2025 across 1 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
1 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $18.80 | 100.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $18.80 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $18.80 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1044 | 217 |
| Lisinopril | Lisinopril | 717 | 148 |
| Metoprolol Succinate | Metoprolol Succinate | 607 | 121 |
| Amlodipine Besylate | Amlodipine Besylate | 566 | 117 |
| Gabapentin | Gabapentin | 426 | 68 |
| Levothyroxine Sodium | Levothyroxine Sodium | 419 | 80 |
| Potassium Chloride | Potassium Chloride | 400 | 79 |
| Warfarin Sodium | Warfarin Sodium | 387 | 36 |
| Omeprazole | Omeprazole | 373 | 76 |
| Losartan Potassium | Losartan Potassium | 338 | 73 |
| Eliquis | Apixaban | 321 | 47 |
| Furosemide | Furosemide | 295 | 50 |
| Tamsulosin Hcl | Tamsulosin Hcl | 281 | 59 |
| Jardiance | Empagliflozin | 271 | 35 |
| Pantoprazole Sodium | Pantoprazole Sodium | 268 | 46 |
| Famotidine | Famotidine | 263 | 51 |
| Metformin Hcl | Metformin Hcl | 248 | 51 |
| Torsemide | Torsemide | 235 | 40 |
| Hydrochlorothiazide | Hydrochlorothiazide | 224 | 53 |
| Sertraline Hcl | Sertraline Hcl | 222 | 36 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 210 | 49 |
| Carvedilol | Carvedilol | 208 | 43 |
| Escitalopram Oxalate | Escitalopram Oxalate | 201 | 45 |
| Clopidogrel | Clopidogrel Bisulfate | 155 | 31 |
| Metformin Hcl Er | Metformin Hcl | 153 | 30 |
| Glimepiride | Glimepiride | 146 | 29 |
| Allopurinol | Allopurinol | 142 | 38 |
| Alendronate Sodium | Alendronate Sodium | 140 | 30 |
| Metoprolol Tartrate | Metoprolol Tartrate | 139 | 28 |
| Simvastatin | Simvastatin | 130 | 34 |
| Meloxicam | Meloxicam | 127 | 30 |
| Chlorthalidone | Chlorthalidone | 122 | 30 |
| Montelukast Sodium | Montelukast Sodium | 119 | 28 |
| Spironolactone | Spironolactone | 112 | 26 |
| Pregabalin | Pregabalin | 99 | 17 |
| Trazodone Hcl | Trazodone Hcl | 90 | 24 |
| Donepezil Hcl | Donepezil Hcl | 89 | 18 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 88 | 30 |
| Prednisone | Prednisone | 86 | 43 |
| Tramadol Hcl | Tramadol Hcl | 84 | 21 |
| Zolpidem Tartrate | Zolpidem Tartrate | 84 | 14 |
| Finasteride | Finasteride | 83 | 14 |
| Xarelto | Rivaroxaban | 83 | 11 |
| Duloxetine Hcl | Duloxetine Hcl | 79 | 22 |
| Azithromycin | Azithromycin | 75 | 27 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 74 | 11 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 70 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 68 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 67 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 67 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 66 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 66 | 13 |
| Myrbetriq | Mirabegron | 66 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 65 | 30 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 63 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 61 | 12 |
| Mounjaro | Tirzepatide | 61 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 57 | 17 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 57 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 57 | 19 |
| Propranolol Hcl | Propranolol Hcl | 56 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 54 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 54 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 53 | 11 |
| Mirtazapine | Mirtazapine | 51 | suppressed |
| Ozempic | Semaglutide | 51 | suppressed |
| Ezetimibe | Ezetimibe | 50 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 48 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 47 | suppressed |
| Levetiracetam | Levetiracetam | 45 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 45 | suppressed |
| Topiramate | Topiramate | 44 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 43 | suppressed |
| Lamotrigine | Lamotrigine | 43 | suppressed |
| Cephalexin | Cephalexin | 42 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 42 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 40 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 40 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 37 | 14 |
| Naproxen | Naproxen | 34 | suppressed |
| Cefdinir | Cefdinir | 33 | 30 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 33 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 33 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 33 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 31 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 30 | suppressed |
| Synthroid | Levothyroxine Sodium | 30 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 29 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 29 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 27 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 27 | suppressed |
| Lorazepam | Lorazepam | 27 | suppressed |
| Amoxicillin | Amoxicillin | 26 | suppressed |
| Estradiol | Estradiol | 26 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 26 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 25 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 25 | suppressed |
| Glipizide Er | Glipizide | 25 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | 13 |
| Sucralfate | Sucralfate | 25 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Lovastatin | Lovastatin | 24 | suppressed |
| Calcitriol | Calcitriol | 23 | suppressed |
| Glipizide | Glipizide | 23 | suppressed |
| Atenolol | Atenolol | 22 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 22 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 22 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 22 | 11 |
| Incruse Ellipta | Umeclidinium Bromide | 22 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 22 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 22 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 21 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 21 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 21 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 21 | suppressed |
| Ibuprofen | Ibuprofen | 20 | suppressed |
| Latanoprost | Latanoprost | 20 | suppressed |
| Ketoconazole | Ketoconazole | 19 | suppressed |
| Trulicity | Dulaglutide | 19 | suppressed |
| Lactulose | Lactulose | 18 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 18 | suppressed |
| Baclofen | Baclofen | 17 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Olanzapine | Olanzapine | 17 | suppressed |
| Sotalol | Sotalol Hcl | 17 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 16 | suppressed |
| Celecoxib | Celecoxib | 16 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 16 | suppressed |
| Colchicine | Colchicine | 15 | suppressed |
| Fluconazole | Fluconazole | 15 | suppressed |
| Gemfibrozil | Gemfibrozil | 15 | suppressed |
| Rybelsus | Semaglutide | 15 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 15 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 14 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 14 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 14 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 14 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 13 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 13 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Temazepam | Temazepam | 13 | suppressed |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Acebutolol Hcl | Acebutolol Hcl | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 12 | 11 |
| Carbamazepine Er | Carbamazepine | 12 | suppressed |
| Clonazepam | Clonazepam | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Vascepa | Icosapent Ethyl | 12 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 11 | suppressed |
| Budesonide Dr | Budesonide | 11 | suppressed |
| Bumetanide | Bumetanide | 11 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 11 | suppressed |
| Humalog | Insulin Lispro | 11 | suppressed |
| Methazolamide | Methazolamide | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $18.80 · 1 records | Otsuka America Pharmaceutical, Inc. | REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error